Skip to content

Dietary Oils in Stress Pilot Study

A Pilot Randomised Controlled Double Blind Intervention Study of the Effects of docosahexaenoic acid-(DHA)-Rich Fish Oil Compared with Olive Oil in Psychological Stress.

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000124235
Enrollment
39
Registered
2009-02-20
Start date
2008-08-13
Completion date
2008-08-20
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of the study is to demonstrate a protective role of omega 3 fatty acids during time of intense psychological stress (exam stress in university students) compared with a placebo.

Interventions

DHA-rich Fish Oil Supplements, 4 capsules per day for 12 weeks. Each capsule contains 1000mg fish oil, containing (DHA) 500mg, and eicosapentaenoic acid (EPA) 100 mg

Sponsors

Blackmores Ltd
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

Fulltime students, aged between 18-45, has normal eating habits, has not radically changed diet in past 3m, consumes less than 2 fish meals per week on average, describes self as someone that experiences a lot of stress under pressure, willing to refrain from other medications during trial

Exclusion criteria

allergy to seafood, aversion to taking fish oil, has taken a course of fish oil in past 3m, has a systemic chronic disease such as diabetes or heart disease, has a history of haemophilia or any type of clotting disorder, has a history of psychiatric illness, history of taking antipsychotics or antidepressants, current infectious, allergic or inflammatory response, any medications in past 2 weeks, non-sterioidal antiinflammatory medications in past 30 days, corticosteroids in past 3m, females with menstrual irregularities, females that are pregnant or lactating, poor venous access, any other condition which in the opinion of the investigators may impact on study outcomes.

Outcome results

None listed

Source: ANZCTR · Data processed: Sep 19, 2026